A strange new conception of how time warps across the universe does away with cosmology’s most mysterious entity, dark energy.
By Stuart Clark
The U.S. DARPA has launched the USX-1 Defiant, a 240-metric-ton unmanned surface vessel (USV) designed for fully autonomous naval missions.
“This indicates that ergothioneine influences the metabolism in a similar way to performance-enhancing agents,” Filipović said. He plans to carry out a study involving healthy human volunteers to evaluate whether the compound can similarly enhance performance in people.
By offering a clearer perspective on how ergothioneine improves muscle health, stress resilience, and cellular defenses, this research sets the stage for new strategies aimed at maintaining good health into advanced age.
As further investigations confirm these findings in humans, the mushroom compound ergothioneine may emerge as a valuable resource for countering age-related diseases and promoting a more robust, active life.
Researchers develop nanoscale 3D printing method to create biodegradable vaccine carriers with controlled release.
American quantum computing startup PsiQuantum announced last week that it has cracked a significant puzzle on the road to making the technology useful: manufacturing quantum chips in large quantities.
PsiQuantum burst out of stealth mode in 2021 with a blockbuster funding announcement. It followed up with two more last year.
The company uses so-called “photonic” quantum computing, which has long been dismissed as impractical.
“Our woolly mouse project drove innovations in areas combining the end to end process from our computational biology analysis tools to our multiplex precision genome engineering technologies,” Lamm told us. “These technologies enable precise and efficient genetic modifications at multiple sites within the genome at the same time, which could help with research focused on addressing the complex multi-genetic age-related diseases in the future.”
By further refining the genetic engineering techniques developed by Colossal, researchers may eventually develop therapies tailored to an individual’s genetic makeup, mitigating the effects of aging at a cellular level.
“Many diseases are multigenic in nature and require deep analysis computationally and being able to edit the genome at multiple sites with high degrees of efficiency to not cause off-target effects,” Lamm told us. “Our end to end process and the further development of our multiplex editing and DNA synthesis capabilities will lead to others being able to use our tools and system to treat these more complicated diseases. Together, these innovations are part of the science focused on developing personalized, targeted therapies to mitigate the effects of aging, accelerate the development of regenerative medicine, and extend both lifespan and healthspan.”
